


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.13%
+31.37%
+8.62%
-2.81%
AMGN
Amgen
$335.76
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
AMGN Price Performance
$315.38 (+6.46%)
$292.4 (+14.83%)
$296.47 (+13.25%)
$296.47 (+13.25%)
AMGN has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

AMGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
AMGN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AMGN Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
MRNA
34.91
-2.72%
BIIB
185.52
-0.74%
EXEL
44.41
-3.83%
CRSP
56.70
-2.10%
CHRS
1.40
-2.10%
What is AMGN current stock price?
What are AMGN stock strengths?
What is AMGN Risk Level?
What is AMGN market cap and volume?
What is AMGN current Stock IQ?
Should I buy AMGN stock right now?
Is AMGN a Strong Buy right now?
What does a 'Strong Buy' rating mean for AMGN?
What does a 'Strong Sell' rating mean for AMGN?
What factors influence AMGN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.13%
+31.37%
+8.62%
-2.81%
AMGN
Amgen
Current Price
$335.76
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Linked to AMGN
MRNA
34.91
-2.72%
BIIB
185.52
-0.74%
EXEL
44.41
-3.83%
CRSP
56.70
-2.10%
CHRS
1.40
-2.10%

AMGN Price Performance
$315.38 (+6.46%)
$292.4 (+14.83%)
$296.47 (+13.25%)
$296.47 (+13.25%)
AMGN Analysts Opinion
AMGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
AMGN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AMGN Street Sentiment is extremely bullish and have positive views on the near-term outlook
AMGN has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
AMGN Stock IQ
AMGN Latest Analysis
Amgen Reaches Analyst Target Price. In recent trading shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $330.74 changing hands for $341.64/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on valuatio
Today
Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs. On Tuesday ) acquired The acquisition values Dark Blue Therapeutics at up to $840 million including .Dark Blue’.s lead candidate DBT 3757 is currently in IND-enabling studies for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).Leukemia is a cancer of the blood-forming tissues like bone marrow causing rapid production of abnormal white ...
Wed Jan 7, 2026
Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline. AMGNs $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader bolstering its oncology pipeline.
Wed Jan 7, 2026
Dow Movers: JPM AMGN. In early trading on Wednesday shares of Amgen topped the list of the days best performing Dow Jones Industrial Average components trading up 2.6%. Year to date Amgen registers a 3.5% gain.And the worst performing Dow component thus far on the day is JPMorgan Chase tradin
Wed Jan 7, 2026
Amgen upgraded to buy at UBS on potential of MariTide olpasiran.
Tue Jan 6, 2026
Amgen acquires Dark Blue Therapeutics for up to $840 million.
Tue Jan 6, 2026
Amgen Acquires Privately-held Dark Blue Therapeutics In $840 Mln Deal . (RTTNews) - Amgen Inc. (AMGN) announced Tuesday its acquisition of UK-based privately-held biotechnology company Dark Blue Therapeutics Ltd. in a transaction valued at up to $840 million.
Tue Jan 6, 2026
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors. In the closing of the recent trading day Amgen (AMGN) stood at $320.71 denoting a -2.12% move from the preceding trading day.
Mon Jan 5, 2026
Strong Results and Pipeline Momentum Power Amgens (AMGN) 2025 Rally. Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Amgen Inc. (NASDAQ:AMGN) has outperformed the broader market this year supported by strong financial results and steady clinical progress even as investors keep an eye on upcoming patent expirations. The stock is up more than 27% since the start [….]
Tue Dec 30, 2025
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It. Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.
Mon Dec 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AMGN Stock trends
AMGN Stock performance
AMGN Stock analysis
AMGN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.